Judith Herman's insights on integrating psychedelic therapy with mindfulness to protect against harm from current systems are discussed in this exploration of trauma and healing.
Bruce Poulter, Marcela Ot’alora
Paul Stamets and Pamela Kryskow discuss the diverse history and potential of psilocybin mushrooms, highlighting their cultural and medical significance in human evolution and mental health treatment. Kryskow emphasizes the
Pam Kryskow, Paul Stamets
Zendo Project shares insights on supporting individuals in non-ordinary states of consciousness, offering skills and practical tips for helping during psychedelic or emotional crises.
Valerie Beltran, Steve Bagley, Chelsea Rose
Dr. Bogenschutz presents quantitative findings from a psilocybin trial for alcohol use disorder, showing reduced alcohol craving and improved mood and cognition. Dr. Agin-Liebes discusses qualitative results on self-awareness and
Gabrielle Agin-Liebes
Psilocybin research journey: investigating its use for treating tobacco addiction. Includes pilot study, comparative efficacy study, and upcoming multi-site clinical trial funded by NIDA.
N,N-Dimethyltryptamine (DMT) is an endogenous substance found in human organs and the brain. A study evaluates the effects of inhaled DMT on brain activity and cognition using EEG and subjective
Dráulio Araújo
Psychedelic-assisted therapy's history, Bill W's admiration, and the need for peer support group understanding are discussed in relation to sobriety, recovery, and psychedelics.
Kevin Franciotti, Reilly Capps, Celeste Alvarez, Danielle Nova, Rick Barnett, Juliana Mulligan
Canadian Psychedelic Survey collected real-world evidence from 2393 Canadian adults on psychedelic use, revealing patterns, effects, and reasons for use. Results may influence policy and treatment approaches.
Philippe Lucas
Sara, from MAPS and Zendo Project, shares insights on community psychedelic use, emphasizing harm reduction, community healing, and balanced perspectives on the powerful effects of psychedelics in social settings.
William Leonard Pickard, once a prominent figure in the drug world, served 20 years in prison for LSD production and now works as a senior advisor for various organizations. His
William Leonard Pickard, Vince Kadlubek